26966 Tofacitinib treats unresponsive vitiligo and elevated thyroid peroxidase antibodies

医学 白癜风 皮肤病科 内科学 银屑病 左旋甲状腺素 胃肠病学 皮密莫司 甲状腺过氧化物酶 托法替尼 内分泌学 甲状腺 类风湿性关节炎 他克莫司 移植
作者
Angela Yen Moore,Samanna Maberry
出处
期刊:Journal of The American Academy of Dermatology [Elsevier BV]
卷期号:85 (3): AB124-AB124 被引量:2
标识
DOI:10.1016/j.jaad.2021.06.515
摘要

A 56-year-old female presented with expanding vitiligo to 35% total body surface area (TBSA) despite treatment with alpha lipoic acid, vitamin C, vitamin E, polypodium leucotomus, topical pimecrolimus, narrowband ultraviolet B, and excimer laser for 2 months. Past medical history was pertinent for Hashimoto thyroiditis treated with levothyroxine with normal levels of thyroid stimulating hormone (TSH) and free thyroxine (FT4), psoriatic arthritis, alopecia, and localized psoriasis on the elbows. Notably, lab tests confirmed normal levels of serum TSH and FT4 but elevated thyroid peroxidase antibodies (TPO) of 795 and elevated thyroglobulin antibodies (TG) of 3. Her endocrinologist denied necessity of treating patients for elevated TPO but stated that patients were only treated with increased dosages of levothyroxine. Because of reported case reports of success in treating vitiligo and FDA-approval for psoriatic arthritis, tofacitinib 5 mg (Tofa) twice daily (BID) was added to the treatment regimen. Serum levels of TPO and TG normalized within 1 month, with simultaneous improvement in vitiligo. Because of gastrointestinal side effects after BID dosing for 5 months, Tofa was decreased to once daily, with continued vitiligo repigmentation. By then, vitiligo had decreased to 12% TBSA, with accompanying improvement in alopecia, psoriatic arthritis, and psoriasis. This case suggests that unstable vitiligo may be associated with elevated TPO and TG, because of a disregard of endocrinologists to treat elevated antibodies, and should be tested in patients with unresponsive vitiligo. Tofacitinib may ameliorate vitiligo not only as a Janus kinase inhibitor but also through an effect on TPO and TG.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
liu发布了新的文献求助10
刚刚
1秒前
lx1199完成签到 ,获得积分10
2秒前
zhu完成签到,获得积分10
2秒前
小小怪发布了新的文献求助30
2秒前
如小美完成签到,获得积分10
4秒前
迟书问剑完成签到 ,获得积分10
4秒前
Nothing发布了新的文献求助10
4秒前
5秒前
孤独星月发布了新的文献求助10
5秒前
请我吃葡萄完成签到 ,获得积分10
5秒前
Maestro_S的应助被Pupupapa采纳,获得10
5秒前
周江阔发布了新的文献求助10
5秒前
5秒前
6秒前
6秒前
直率万声发布了新的文献求助10
7秒前
7秒前
桐桐的应助被健康的魔镜采纳,获得10
8秒前
绿地土狗完成签到,获得积分10
8秒前
ding的应助被nikola采纳,获得10
9秒前
科研通AI6.4的应助被筑梦之鱼采纳,获得10
9秒前
wxwx发布了新的文献求助10
10秒前
加油完成签到 ,获得积分10
12秒前
12秒前
13秒前
13秒前
15秒前
qiqi发布了新的文献求助10
16秒前
16秒前
wanci的应助被小小怪采纳,获得10
16秒前
wangbw发布了新的文献求助10
16秒前
17秒前
Pupupapa完成签到,获得积分20
17秒前
lulu完成签到,获得积分10
18秒前
Bai发布了新的文献求助10
18秒前
Akim的应助被blinkals57采纳,获得10
18秒前
ui24发布了新的文献求助10
18秒前
18秒前
淡定访琴完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178807
求助须知:如何正确求助?哪些是违规求助? 9569558
关于积分的说明 21805222
捐赠科研通 7773974
什么是DOI,文献DOI怎么找? 3432933
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478593